Laboratorios Farmaceuticos Rovi, S.A. (BME:ROVI)
Spain · Delayed Price · Currency is EUR 58.25
+0.40 (0.69%)
Sep 16, 2026, 5:35 PM CET
BME:ROVI Market Cap
BME:ROVI has a market cap or net worth of €2.96 billion as of September 16, 2026. Its market cap has decreased by -3.43% in one year.
Market Cap
2.96B
Enterprise Value
2.95B
Revenue
773.05M
Ranking
n/a
PE Ratio
15.98
Stock Price
€58.25
ChartMarket Cap Chart
Since December 18, 2007, BME:ROVI's market cap has increased from 356.09K to 2.96B, an increase of 830,763.67%. That is a compound annual growth rate of 61.79%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 16, 2026 | 2.96B | -8.91% |
| Dec 31, 2025 | 3.25B | 0.87% |
| Dec 31, 2024 | 3.22B | 0.22% |
| Dec 29, 2023 | 3.21B | 66.93% |
| Dec 30, 2022 | 1.92B | -53.49% |
| Dec 30, 2021 | 4.14B | 97.10% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Grifols | 5.75B |
| Almirall | 2.23B |
| Faes Farma | 1.41B |
| Pharma Mar | 1.33B |
| Clínica Baviera | 907.48M |
| Oryzon Genomics | 229.00M |
| Atrys Health | 222.41M |
| Prim, S.A. | 216.01M |